Development
Nutrien Ltd.
NTR
$55.69
-$0.02-0.04%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 28.08B | 29.97B | 32.58B | 35.47B | 37.01B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.08B | 29.97B | 32.58B | 35.47B | 37.01B |
| Cost of Revenue | 19.61B | 20.36B | 21.34B | 21.39B | 21.59B |
| Gross Profit | 8.47B | 9.61B | 11.25B | 14.08B | 15.42B |
| SG&A Expenses | 4.01B | 3.95B | 3.96B | 3.99B | 4.05B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 907.00M | 900.00M | 1.16B | 1.35B | 1.53B |
| Total Operating Expenses | 24.53B | 25.20B | 26.46B | 26.73B | 27.17B |
| Operating Income | 3.55B | 4.76B | 6.13B | 8.74B | 9.84B |
| Income Before Tax | 1.95B | 3.34B | 5.23B | 9.13B | 10.25B |
| Income Tax Expenses | 670.00M | 1.12B | 1.51B | 2.25B | 2.56B |
| Earnings from Continuing Operations | 1.28K | 2.22K | 3.73K | 6.88K | 7.69K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -24.00M | -26.00M | -25.00M | -25.00M | -27.00M |
| Net Income | 1.26B | 2.20B | 3.70B | 6.85B | 7.66B |
| EBIT | 3.55B | 4.76B | 6.13B | 8.74B | 9.84B |
| EBITDA | 5.33B | 6.55B | 7.88B | 10.44B | 11.51B |
| EPS Basic | 2.53 | 4.33 | 7.13 | 12.77 | 14.13 |
| Normalized Basic EPS | 3.44 | 5.01 | 6.82 | 9.74 | 10.90 |
| EPS Diluted | 2.53 | 4.32 | 7.11 | 12.73 | 14.08 |
| Normalized Diluted EPS | 3.44 | 5.00 | 6.81 | 9.71 | 10.87 |
| Average Basic Shares Outstanding | 1.99B | 2.01B | 2.05B | 2.10B | 2.15B |
| Average Diluted Shares Outstanding | 1.99B | 2.01B | 2.05B | 2.11B | 2.16B |
| Dividend Per Share | 2.12 | 2.07 | 2.02 | 1.97 | 1.92 |
| Payout Ratio | 82.04% | 46.45% | 27.54% | 14.88% | 13.46% |